Huntington's disease deciphered
Researchers at the University of Illinois at Chicago College of Medicine have discovered how the mutated huntingtin gene acts on the nervous system to create the devastation of Huntington's disease. The report of their findings is available in Nature Neuroscience online. The researchers were able to show that the mutated huntingtin gene activates a particular enzyme, called JNK3, which is expressed only in neurons and, further, to show what effect activation of that enzyme has on neuron function.
Huntington's disease is an adult onset neurodegenerative disease marked by progressive mental and physical deterioration. It has been known for more than a decade that everyone who develops the disease has mutations in a particular gene, called huntingtin, according to Scott Brady, professor and head of anatomy and cell biology at the UIC College of Medicine.
"There are several puzzling aspects of this disease," said Brady, who is co-principal investigator on the study. "First, the mutation is there from day one. How is it that people are born with a perfectly functioning nervous system, despite the mutation, but as they grow up into their 30s and 40s they start to develop these debilitating symptoms? We need to understand why the protein is bad at 40 but it wasn't bad at 4."
The second problem, according to Brady, is that the gene is expressed not just in the nervous system but in other parts of the body. However, the only part of the body that is affected is the nervous system. Why are neurons being affected?
Brady, Gerardo Morfini, assistant professor of anatomy and cell biology at UIC and co-principal investigator of the study, and their colleagues began looking for a mechanism that could explain all the pieces of the puzzle. They found that at extremely low concentrations, huntingtin was a potent inhibitor of axonal transport, the system within the neuron that shuttles proteins from the cell body where they are synthesized to the synaptic terminals where they are needed.
A neuron's critical role in making connections may require it to make the cellular trunk, called an axon, between the cell body and the synaptic terminal to be very long. Some cells have axons that reach half the body's length -- for a tall person, a meter or more. But even in the brain, axonal projections are very long compared to other cells. In addition to the challenge of distance, neurons are very complex cells with many specialized areas necessary to carry out synaptic connections, requiring a robust transport system.
"Inhibition of neuronal transport is enough to explain what is happening in Huntington's," said Brady. Loss of delivery of materials to the terminals results in loss of transmission of signals from the neuron. Loss of signal transmission causes the neurons to begin to die back, leading to reduced transmissions, more dying back and eventual neuronal cell death.
This mechanism also explains the late onset of the disease, Brady said. Activation of JNK3 reduces transport but does not eliminate it. Young neurons have a robust transport system, but transport gradually declines with age.
"If you take a hit when you're very young, you still are making more and transporting more proteins in each neuron than you need," Brady said. "But as you get older and older, the neuron produces and transports less. Each hit diminishes the system further. Eventually, the neuron falls below the threshold needed to maintain cell health."
Brady's group has also linked this pattern of progressive neurodegeneration -- marked by a loss of signaling between neurons, a slow dying back of neurons, and eventual neuron death -- to damage to the transport system in several other hereditary adult-onset neurodegenerative diseases and to Alzheimer's disease.
"There is a common theme and a common Achilles heel of the neuron that underlies all these diseases," Brady said. "We've invented a word, dysferopathy, (from the Greek 'fero', to carry or transport) for these adult-onset neurodegenerative diseases. All have disruption of the axonal transport system in common."
Source: University of Illinois at Chicago
Related
- Caltech researchers show efficacy of gene therapy in mouse models of Huntington's diseaseFri, 30 Oct 2009, 13:22:38 EDT
- Huntington's disease: catching it earlyMon, 14 Jul 2008, 12:49:39 EDT
- Researchers find potential treatment for Huntington's diseaseSun, 15 Nov 2009, 13:49:31 EST
- Researchers link Huntington's disease to overactive immune response in the brainMon, 14 Jul 2008, 13:28:18 EDT
- Researchers estimate risk of transmission of Huntington's disease to offspring among male carriersTue, 9 Jun 2009, 11:24:26 EDT
Other sources
- Huntington's disease decipheredfrom Science CentricMon, 15 Jun 2009, 18:28:08 EDT
- Huntington's Disease Decipheredfrom Science DailySun, 14 Jun 2009, 16:28:15 EDT
- Huntington's disease decipheredfrom PhysorgSun, 14 Jun 2009, 14:14:16 EDT
- Huntington's disease decipheredfrom Science BlogSun, 14 Jun 2009, 13:42:07 EDT
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Learn more about
Popular science news articles
No popular news yet
No popular news yet
- Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss
- Implant-based cancer vaccine is first to eliminate tumors in mice
- Surface bacteria maintain skin's healthy balance
- Is global warming unstoppable?
- Polyphenols and polyunsaturated fatty acids boost the birth of new neurons
- New evidence that dark chocolate helps ease emotional stress
- African desert rift confirmed as new ocean in the making
- Nanoparticles used in common household items caused genetic damage in mice
- New study links vitamin D deficiency to cardiovascular disease and death
- Therapy 32 times more cost effective at increasing happiness than money